ECONOMIC IMPACT OF A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION PROGRAMME IN A MEXICAN CORPORATE SETTING

被引：1
|
作者：
Huicochea-Bartelt, J. L. [1 ]
Mucino-Ortega, E. [1 ]
Vargas-Valencia, J. J. [2 ]
机构：
[1] Pfizer SA CV, Ciudad De Mexico, Mexico
[2] Econopharma Consulting SA CV, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1612
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN69
引用
下载
收藏
页码：A277 / A277
页数：1
相关论文
共 50 条
  • [21] Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13-Valent polysaccharide conjugate vaccine
    Alicino, C.
    Barberis, I.
    Orsi, A.
    Durando, P.
    MINERVA MEDICA, 2014, 105 (01) : 89 - 97
  • [22] 13-Valent pneumococcal conjugate vaccine utilization in the primary care setting.
    Lomberk, Mary
    Rattray, Deanna
    Bean, Rebecca
    PHARMACOTHERAPY, 2016, 36 (07): : E110 - E110
  • [23] Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology
    Zhao, Alice S.
    Boyle, Sean
    Butrymowicz, Anna
    Engle, Robert D.
    Roberts, Jason M.
    Mouzakes, Jason
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2014, 78 (03) : 499 - 503
  • [24] The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly
    van Werkhoven, Cornelis H.
    Huijts, Susanne M.
    Bolkenbaas, Marieke
    Grobbee, Diederick E.
    Bonten, Marc J. M.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (12) : 1835 - 1838
  • [25] Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
    Theilacker, Christian
    Hilton, Betsy
    Jiang, Qin
    Gessner, Bradford D.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1641 - 1642
  • [26] Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage Among American Indians
    Grant, Lindsay R.
    Hammitt, Laura L.
    O'Brien, Sarah E.
    Jacobs, Michael R.
    Donaldson, Connie
    Weatherholtz, Robert C.
    Reid, Raymond
    Santosham, Mathuram
    O'Brien, Katherine L.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (08) : 907 - 914
  • [27] Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis
    Chapman, Ruth
    Sutton, Kelly
    Dillon-Murphy, Desmond
    Patel, Shreeya
    Hilton, Betsy
    Farkouh, Ray
    Wasserman, Matt
    VACCINE, 2020, 38 (45) : 7138 - 7145
  • [28] Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine
    Ceyhan, Mehmet
    JOURNAL OF PEDIATRIC INFECTION, 2011, 5 (02): : 68 - 73
  • [29] Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States
    Rubin, Jaime L.
    McGarry, Lisa J.
    Strutton, David R.
    Klugman, Keith P.
    Pelton, Stephen I.
    Gilmore, Kristen E.
    Weinstein, Milton C.
    VACCINE, 2010, 28 (48) : 7634 - 7643
  • [30] 13-valent pneumococcal conjugate vaccine (PCV13)
    Jefferies, Johanna M. C.
    Macdonald, Emily
    Faust, Saul N.
    Clarke, Stuart C.
    HUMAN VACCINES, 2011, 7 (10): : 1012 - 1018
12345